INJECTABLE

Trineurosol HP Injection, 5ml

Trineurosol HP Injection, 5ml

By WOCKHARDT

Can't sell this online, but WhatsApp us to book your order!
Enquire Now

Out of Stock

Pack - 5mL
Expires on or after: Feb, 2028

Prescription Required question

Title

Check Availability

Rapid 3-4 Day Delivery,Tiny Extra Fee!

  • AnimealPet Safe
  • AnimealBest Quality
  • AnimealFast Delivery
  • AnimealSecure Payment
View full details

About Trineurosol HP Injection

Trineurosol HP Injection is an injection from Wockhardt that contains hydroxocobalamin (vitamin B12). Hydroxocobalamin is a long-acting form of vitamin B12.

Vets commonly use hydroxocobalamin (vitamin B12) for B12 deficiency and nerve support. Your vet will confirm that it suits your animal and decide the dose and how often it is given.

Prescription Notice

This is a prescription medicine. Animeal dispenses it only against a valid prescription from a registered veterinarian. You can upload the prescription at checkout or send it on WhatsApp to +91 90041 57093.

Composition

Active ingredients listed for this product. The exact strength is printed on the pack.

Ingredient Type
Hydroxocobalamin (vitamin B12) B vitamin

How to Use

  • Given by a vet. This injection should be given by a vet, or by someone your vet has trained, using the route, dose and schedule the vet sets.
  • Handling. Use a new sterile needle and syringe each time. Do not use the vial if the liquid looks cloudy or has particles, unless it is a suspension meant to look that way.

Safety and Precautions

  • Tell your vet about any other medicines or supplements your pet takes, and if your pet is pregnant, nursing or has liver or kidney problems.

Also in: Injectables for Farm Animals · Injectables for Dogs · Farm Animal Products

Product Information

Detail Information
Brand Wockhardt
Manufacturer Wockhardt Ltd., Mumbai, India
Active ingredients Hydroxocobalamin (vitamin B12)
Form Injection
Pack size 5ml
Suitable for Animals
Prescription Required
Sold by Goodman Vetcare Pvt. Ltd. (Animeal), Warehouse No - 501 5th floor, Bharat industrial estate, Tokershi Jivraj Rd, Sewree West, Sindhu Nagar, Sewri, Mumbai, Maharashtra 400015

This product requires a valid prescription from a registered veterinarian. Animeal shares this information for educational purposes only. Always consult your vet before use.

Definitive Treatment for Vitamin B12 Deficiency Anaemia: the single most important and clinically validated veterinary application of parenteral Hydroxocobalamin providing rapid, complete, and reliable correction of B12 deficiency megaloblastic and macrocytic anaemia in dogs, cats, and large animals where oral B12 supplementation cannot be reliably absorbed. Haematological response including reticulocytosis, rising haemoglobin, and normalisation of red blood cell morphology is typically observed within the first 5 to 10 days of initiating parenteral B12 therapy

Essential Support for Exocrine Pancreatic Insufficiency (EPI): one of the most clinically important veterinary indications for parenteral B12 in dogs EPI causes profound malabsorption of dietary Vitamin B12 through multiple mechanisms including loss of intrinsic factor secretion, bacterial overgrowth consuming dietary B12, and mucosal malabsorption. Virtually all dogs with EPI have significant B12 deficiency that cannot be corrected by oral supplementation alone, making regular parenteral Hydroxocobalamin injection an essential component of comprehensive EPI management alongside enzyme replacement therapy

Chronic Intestinal Malabsorption & Inflammatory Bowel Disease: cats and dogs with chronic enteropathies, protein-losing enteropathy, severe IBD, and intestinal lymphangiectasia frequently develop clinically significant B12 deficiency due to impaired ileal absorption of the B12-intrinsic factor complex parenteral Hydroxocobalamin bypasses this impaired absorptive pathway entirely, delivering therapeutic B12 directly into the systemic circulation regardless of gastrointestinal absorptive status

Neurological Support & Peripheral Neuropathy Management: Vitamin B12 is the essential cofactor for adenosylcobalamin-dependent enzymes responsible for maintaining the structural and functional integrity of the myelin sheath that insulates peripheral nerve axons. B12 deficiency causes progressive demyelination of peripheral nerves resulting in weakness, ataxia, proprioceptive deficits, and sensory neuropathy parenteral Hydroxocobalamin arrests this neurological deterioration and supports myelin repair and remyelination when initiated before irreversible axonal damage occurs

Recovery Support in Debilitated, Post-Surgical & Chronically Ill Animals: the B-complex metabolic roles of Vitamin B12 in energy metabolism, protein synthesis, and DNA replication make it an important supportive supplement for debilitated, post-surgical, anorexic, and chronically ill animals requiring intensive nutritional rehabilitation supporting faster recovery, improved appetite, and restoration of cellular metabolic function

Supports Appetite Stimulation & Weight Gain: clinical experience consistently demonstrates that B12-deficient animals particularly cats with chronic disease and dogs with EPI show significant improvement in appetite, food intake, and body weight following correction of B12 deficiency with parenteral Hydroxocobalamin, as B12 plays a fundamental role in the hypothalamic regulatory pathways that control appetite and satiety

Superior Plasma Retention & Tissue Saturation vs Cyanocobalamin: the significantly superior plasma protein binding and longer half-life of Hydroxocobalamin compared to Cyanocobalamin means that a single therapeutic injection achieves higher peak tissue B12 concentrations that are maintained for longer delivering more complete tissue B12 saturation and a more durable therapeutic response with fewer injections required to maintain adequate B12 status in deficient patients

Cyanide Antidote Action: a unique additional clinical property of Hydroxocobalamin not shared by other B12 forms the cobalt centre of Hydroxocobalamin has an extremely high binding affinity for cyanide ions, forming the stable, non-toxic cyanocobalamin compound that is safely eliminated in urine. This property has been exploited in emergency medicine for cyanide poisoning antidote therapy a use that veterinarians may encounter in cases of smoke inhalation or toxic plant ingestion in companion animals

How to Use:

For intramuscular (IM) or subcutaneous (SC) administration by or under the direct supervision of a licensed veterinarian only. Inspect each ampoule visually before use the solution should be clear, deep red in colour, and free from particulate matter. Do not use if the solution appears cloudy, discoloured, or contains visible particles. Draw the required dose into a sterile syringe using aseptic technique. Administer by deep intramuscular injection into an appropriate injection site or by subcutaneous injection as clinically appropriate. Protect drawn solution from light Hydroxocobalamin is photosensitive and should be administered promptly after drawing into the syringe.

Storage Advice:

Store Trineurosol-HP Injection below 25°C in a cool, dry place. Protect strictly from light Hydroxocobalamin is highly photosensitive and exposure to light causes rapid chemical degradation and loss of potency. Store in the original carton until the point of use. Do not freeze. Keep out of reach of children. Do not use after the expiry date printed on the ampoule label and outer carton. Use immediately after opening do not store opened or partially used ampoules.

About the Brand:

Trineurosol-HP is manufactured by Tridoss Laboratories Pvt. Ltd. a trusted Indian pharmaceutical manufacturer with a strong track record of delivering consistent quality pharmaceutical injectable formulations to healthcare professionals and veterinarians across India. With manufacturing facilities operating under strict GMP quality standards and a commitment to pharmaceutical-grade active ingredient purity and concentration accuracy in every ampoule, Tridoss Laboratories ensures that every dose of Trineurosol-HP delivers the reliable, precisely dosed, biologically superior Hydroxocobalamin that veterinarians and their animal patients depend upon for consistent therapeutic outcomes. Their commitment to accessible, quality-assured pharmaceutical manufacturing aligns perfectly with Animeal's mission to provide registered veterinary professionals across India with reliable procurement access to the full spectrum of veterinary pharmaceutical needs.

Disclaimer:

Trineurosol-HP Injection is a prescription-only injectable medicine that must be prescribed and administered exclusively by or under the direct supervision of a licensed veterinarian. It is not available for self-administration or over-the-counter dispensing. Vitamin B12 deficiency in companion animals is frequently a clinical sign of significant underlying disease including exocrine pancreatic insufficiency, inflammatory bowel disease, intestinal lymphangiectasia, and chronic enteropathy that requires comprehensive veterinary diagnosis and management beyond B12 supplementation alone. Always investigate and address the underlying cause of B12 deficiency in parallel with parenteral B12 repletion therapy. Serum Vitamin B12 measurement before and during therapy is recommended where available to guide therapeutic decision-making and monitor response. Animeal facilitates enquiry and procurement for registered veterinary professionals this product is available for veterinary clinic and hospital procurement only.

Q: Why is Hydroxocobalamin preferred over Cyanocobalamin for veterinary parenteral B12 therapy?
Hydroxocobalamin offers three clinically important pharmacokinetic advantages over the more commonly available and cheaper Cyanocobalamin form. First, it binds avidly to plasma transcobalamin proteins, achieving higher peak tissue B12 concentrations and maintaining them for significantly longer following injection. Second, its longer plasma half-life means effective therapeutic B12 tissue levels are maintained between injections for a more extended period reducing injection frequency requirements and improving practical treatment compliance. Third, unlike Cyanocobalamin which requires hepatic conversion before becoming biologically active, Hydroxocobalamin enters the active coenzyme pool directly delivering faster and more complete therapeutic action in the methylcobalamin and adenosylcobalamin pathways critical for haematological and neurological health respectively.
Q: How quickly will I see clinical improvement after starting parenteral B12 therapy in a B12-deficient dog or cat?
The haematological response to parenteral Hydroxocobalamin therapy in B12-deficient animals is typically rapid and clinically measurable. A reticulocytosis (increase in immature red blood cell precursors in circulation the first sign of haematopoietic recovery) is usually detectable within 5 to 7 days of the first injection. Rising haemoglobin and improving packed cell volume are typically measurable within 2 to 3 weeks. Clinical improvement in appetite, energy level, and body weight in dogs with EPI and cats with chronic disease is often noticed by owners within 2 to 4 weeks of initiating regular parenteral B12 therapy. Neurological improvement in animals with B12 deficiency neuropathy is typically slower requiring 4 to 8 weeks of therapy and is only achievable if treatment is initiated before irreversible axonal damage has occurred.
Q: Why can't B12-deficient animals with EPI or IBD simply take oral B12 supplements instead of injections?
In healthy animals with intact gastrointestinal function, dietary Vitamin B12 absorption occurs through a complex process involving intrinsic factor secretion by the pancreas and stomach, B12-intrinsic factor complex formation, and specific receptor-mediated absorption in the ileum. In dogs with EPI, this process is severely impaired through multiple mechanisms loss of pancreatic intrinsic factor secretion, secondary small intestinal bacterial overgrowth consuming dietary B12 before it can be absorbed, and mucosal malabsorption. In cats and dogs with IBD and chronic enteropathy, ileal mucosal damage impairs receptor-mediated absorption of the B12-intrinsic factor complex. In both conditions, oral B12 supplementation regardless of dose cannot reliably achieve or maintain adequate serum and tissue B12 levels, making parenteral injection the only therapeutically reliable route for B12 repletion in these patients.
Q: Is long-term parenteral B12 supplementation safe for dogs and cats?
Yes Vitamin B12 is a water-soluble vitamin with an extremely wide therapeutic index and no known toxicity at any clinically relevant dose in dogs or cats. Excess Hydroxocobalamin that is not bound to plasma proteins and tissue receptors is safely eliminated in the urine. Long-term monthly or bi-monthly parenteral B12 maintenance therapy is routinely and safely used in dogs with EPI and cats with chronic intestinal disease throughout their entire lives with no adverse effects associated with long-term use. Regular monitoring of serum B12 levels where available helps optimise injection frequency and confirm that maintenance therapy is achieving adequate tissue B12 saturation.
Q: How can veterinary clinics procure Trineurosol-HP Hydroxocobalamin 1000mcg Injection through Animeal?
Registered veterinary practitioners, veterinary clinics, and animal hospitals can enquire about and procure Trineurosol-HP Injection through Animeal's dedicated veterinary pharmaceutical enquiry channel. Please use the Enquire Now button on this product page or contact our veterinary pharma team directly via WhatsApp or phone with your valid veterinary prescription and practice registration details. Our team will respond promptly with product availability, current pricing, pack size options, and delivery arrangements to your registered clinic or hospital address anywhere across India.
Trineurosol HP Injection, 5ml - Animeal
Trineurosol HP Injection, 5ml - Animeal
INJECTABLE
🚚 Free Delivery Above ₹499 - Pan India
10 DaysEasy Returns
100%Authentic
SecurePayments
INJECTABLE

Trineurosol HP Injection, 5ml

By WOCKHARDT
WhatsApp us to book your order!

Out of Stock

Expires on or after: Feb, 2028
Size

Prescription Required question

Check Availability

About Trineurosol HP Injection

Trineurosol HP Injection is an injection from Wockhardt that contains hydroxocobalamin (vitamin B12). Hydroxocobalamin is a long-acting form of vitamin B12.

Vets commonly use hydroxocobalamin (vitamin B12) for B12 deficiency and nerve support. Your vet will confirm that it suits your animal and decide the dose and how often it is given.

Prescription Notice

This is a prescription medicine. Animeal dispenses it only against a valid prescription from a registered veterinarian. You can upload the prescription at checkout or send it on WhatsApp to +91 90041 57093.

Composition

Active ingredients listed for this product. The exact strength is printed on the pack.

Ingredient Type
Hydroxocobalamin (vitamin B12) B vitamin

How to Use

  • Given by a vet. This injection should be given by a vet, or by someone your vet has trained, using the route, dose and schedule the vet sets.
  • Handling. Use a new sterile needle and syringe each time. Do not use the vial if the liquid looks cloudy or has particles, unless it is a suspension meant to look that way.

Safety and Precautions

  • Tell your vet about any other medicines or supplements your pet takes, and if your pet is pregnant, nursing or has liver or kidney problems.

Also in: Injectables for Farm Animals · Injectables for Dogs · Farm Animal Products

Product Information

Detail Information
Brand Wockhardt
Manufacturer Wockhardt Ltd., Mumbai, India
Active ingredients Hydroxocobalamin (vitamin B12)
Form Injection
Pack size 5ml
Suitable for Animals
Prescription Required
Sold by Goodman Vetcare Pvt. Ltd. (Animeal), Warehouse No - 501 5th floor, Bharat industrial estate, Tokershi Jivraj Rd, Sewree West, Sindhu Nagar, Sewri, Mumbai, Maharashtra 400015

This product requires a valid prescription from a registered veterinarian. Animeal shares this information for educational purposes only. Always consult your vet before use.

Definitive Treatment for Vitamin B12 Deficiency Anaemia: the single most important and clinically validated veterinary application of parenteral Hydroxocobalamin providing rapid, complete, and reliable correction of B12 deficiency megaloblastic and macrocytic anaemia in dogs, cats, and large animals where oral B12 supplementation cannot be reliably absorbed. Haematological response including reticulocytosis, rising haemoglobin, and normalisation of red blood cell morphology is typically observed within the first 5 to 10 days of initiating parenteral B12 therapy

Essential Support for Exocrine Pancreatic Insufficiency (EPI): one of the most clinically important veterinary indications for parenteral B12 in dogs EPI causes profound malabsorption of dietary Vitamin B12 through multiple mechanisms including loss of intrinsic factor secretion, bacterial overgrowth consuming dietary B12, and mucosal malabsorption. Virtually all dogs with EPI have significant B12 deficiency that cannot be corrected by oral supplementation alone, making regular parenteral Hydroxocobalamin injection an essential component of comprehensive EPI management alongside enzyme replacement therapy

Chronic Intestinal Malabsorption & Inflammatory Bowel Disease: cats and dogs with chronic enteropathies, protein-losing enteropathy, severe IBD, and intestinal lymphangiectasia frequently develop clinically significant B12 deficiency due to impaired ileal absorption of the B12-intrinsic factor complex parenteral Hydroxocobalamin bypasses this impaired absorptive pathway entirely, delivering therapeutic B12 directly into the systemic circulation regardless of gastrointestinal absorptive status

Neurological Support & Peripheral Neuropathy Management: Vitamin B12 is the essential cofactor for adenosylcobalamin-dependent enzymes responsible for maintaining the structural and functional integrity of the myelin sheath that insulates peripheral nerve axons. B12 deficiency causes progressive demyelination of peripheral nerves resulting in weakness, ataxia, proprioceptive deficits, and sensory neuropathy parenteral Hydroxocobalamin arrests this neurological deterioration and supports myelin repair and remyelination when initiated before irreversible axonal damage occurs

Recovery Support in Debilitated, Post-Surgical & Chronically Ill Animals: the B-complex metabolic roles of Vitamin B12 in energy metabolism, protein synthesis, and DNA replication make it an important supportive supplement for debilitated, post-surgical, anorexic, and chronically ill animals requiring intensive nutritional rehabilitation supporting faster recovery, improved appetite, and restoration of cellular metabolic function

Supports Appetite Stimulation & Weight Gain: clinical experience consistently demonstrates that B12-deficient animals particularly cats with chronic disease and dogs with EPI show significant improvement in appetite, food intake, and body weight following correction of B12 deficiency with parenteral Hydroxocobalamin, as B12 plays a fundamental role in the hypothalamic regulatory pathways that control appetite and satiety

Superior Plasma Retention & Tissue Saturation vs Cyanocobalamin: the significantly superior plasma protein binding and longer half-life of Hydroxocobalamin compared to Cyanocobalamin means that a single therapeutic injection achieves higher peak tissue B12 concentrations that are maintained for longer delivering more complete tissue B12 saturation and a more durable therapeutic response with fewer injections required to maintain adequate B12 status in deficient patients

Cyanide Antidote Action: a unique additional clinical property of Hydroxocobalamin not shared by other B12 forms the cobalt centre of Hydroxocobalamin has an extremely high binding affinity for cyanide ions, forming the stable, non-toxic cyanocobalamin compound that is safely eliminated in urine. This property has been exploited in emergency medicine for cyanide poisoning antidote therapy a use that veterinarians may encounter in cases of smoke inhalation or toxic plant ingestion in companion animals

How to Use:

For intramuscular (IM) or subcutaneous (SC) administration by or under the direct supervision of a licensed veterinarian only. Inspect each ampoule visually before use the solution should be clear, deep red in colour, and free from particulate matter. Do not use if the solution appears cloudy, discoloured, or contains visible particles. Draw the required dose into a sterile syringe using aseptic technique. Administer by deep intramuscular injection into an appropriate injection site or by subcutaneous injection as clinically appropriate. Protect drawn solution from light Hydroxocobalamin is photosensitive and should be administered promptly after drawing into the syringe.

Storage Advice:

Store Trineurosol-HP Injection below 25°C in a cool, dry place. Protect strictly from light Hydroxocobalamin is highly photosensitive and exposure to light causes rapid chemical degradation and loss of potency. Store in the original carton until the point of use. Do not freeze. Keep out of reach of children. Do not use after the expiry date printed on the ampoule label and outer carton. Use immediately after opening do not store opened or partially used ampoules.

About the Brand:

Trineurosol-HP is manufactured by Tridoss Laboratories Pvt. Ltd. a trusted Indian pharmaceutical manufacturer with a strong track record of delivering consistent quality pharmaceutical injectable formulations to healthcare professionals and veterinarians across India. With manufacturing facilities operating under strict GMP quality standards and a commitment to pharmaceutical-grade active ingredient purity and concentration accuracy in every ampoule, Tridoss Laboratories ensures that every dose of Trineurosol-HP delivers the reliable, precisely dosed, biologically superior Hydroxocobalamin that veterinarians and their animal patients depend upon for consistent therapeutic outcomes. Their commitment to accessible, quality-assured pharmaceutical manufacturing aligns perfectly with Animeal's mission to provide registered veterinary professionals across India with reliable procurement access to the full spectrum of veterinary pharmaceutical needs.

Disclaimer:

Trineurosol-HP Injection is a prescription-only injectable medicine that must be prescribed and administered exclusively by or under the direct supervision of a licensed veterinarian. It is not available for self-administration or over-the-counter dispensing. Vitamin B12 deficiency in companion animals is frequently a clinical sign of significant underlying disease including exocrine pancreatic insufficiency, inflammatory bowel disease, intestinal lymphangiectasia, and chronic enteropathy that requires comprehensive veterinary diagnosis and management beyond B12 supplementation alone. Always investigate and address the underlying cause of B12 deficiency in parallel with parenteral B12 repletion therapy. Serum Vitamin B12 measurement before and during therapy is recommended where available to guide therapeutic decision-making and monitor response. Animeal facilitates enquiry and procurement for registered veterinary professionals this product is available for veterinary clinic and hospital procurement only.

Q: Why is Hydroxocobalamin preferred over Cyanocobalamin for veterinary parenteral B12 therapy?
Hydroxocobalamin offers three clinically important pharmacokinetic advantages over the more commonly available and cheaper Cyanocobalamin form. First, it binds avidly to plasma transcobalamin proteins, achieving higher peak tissue B12 concentrations and maintaining them for significantly longer following injection. Second, its longer plasma half-life means effective therapeutic B12 tissue levels are maintained between injections for a more extended period reducing injection frequency requirements and improving practical treatment compliance. Third, unlike Cyanocobalamin which requires hepatic conversion before becoming biologically active, Hydroxocobalamin enters the active coenzyme pool directly delivering faster and more complete therapeutic action in the methylcobalamin and adenosylcobalamin pathways critical for haematological and neurological health respectively.
Q: How quickly will I see clinical improvement after starting parenteral B12 therapy in a B12-deficient dog or cat?
The haematological response to parenteral Hydroxocobalamin therapy in B12-deficient animals is typically rapid and clinically measurable. A reticulocytosis (increase in immature red blood cell precursors in circulation the first sign of haematopoietic recovery) is usually detectable within 5 to 7 days of the first injection. Rising haemoglobin and improving packed cell volume are typically measurable within 2 to 3 weeks. Clinical improvement in appetite, energy level, and body weight in dogs with EPI and cats with chronic disease is often noticed by owners within 2 to 4 weeks of initiating regular parenteral B12 therapy. Neurological improvement in animals with B12 deficiency neuropathy is typically slower requiring 4 to 8 weeks of therapy and is only achievable if treatment is initiated before irreversible axonal damage has occurred.
Q: Why can't B12-deficient animals with EPI or IBD simply take oral B12 supplements instead of injections?
In healthy animals with intact gastrointestinal function, dietary Vitamin B12 absorption occurs through a complex process involving intrinsic factor secretion by the pancreas and stomach, B12-intrinsic factor complex formation, and specific receptor-mediated absorption in the ileum. In dogs with EPI, this process is severely impaired through multiple mechanisms loss of pancreatic intrinsic factor secretion, secondary small intestinal bacterial overgrowth consuming dietary B12 before it can be absorbed, and mucosal malabsorption. In cats and dogs with IBD and chronic enteropathy, ileal mucosal damage impairs receptor-mediated absorption of the B12-intrinsic factor complex. In both conditions, oral B12 supplementation regardless of dose cannot reliably achieve or maintain adequate serum and tissue B12 levels, making parenteral injection the only therapeutically reliable route for B12 repletion in these patients.
Q: Is long-term parenteral B12 supplementation safe for dogs and cats?
Yes Vitamin B12 is a water-soluble vitamin with an extremely wide therapeutic index and no known toxicity at any clinically relevant dose in dogs or cats. Excess Hydroxocobalamin that is not bound to plasma proteins and tissue receptors is safely eliminated in the urine. Long-term monthly or bi-monthly parenteral B12 maintenance therapy is routinely and safely used in dogs with EPI and cats with chronic intestinal disease throughout their entire lives with no adverse effects associated with long-term use. Regular monitoring of serum B12 levels where available helps optimise injection frequency and confirm that maintenance therapy is achieving adequate tissue B12 saturation.
Q: How can veterinary clinics procure Trineurosol-HP Hydroxocobalamin 1000mcg Injection through Animeal?
Registered veterinary practitioners, veterinary clinics, and animal hospitals can enquire about and procure Trineurosol-HP Injection through Animeal's dedicated veterinary pharmaceutical enquiry channel. Please use the Enquire Now button on this product page or contact our veterinary pharma team directly via WhatsApp or phone with your valid veterinary prescription and practice registration details. Our team will respond promptly with product availability, current pricing, pack size options, and delivery arrangements to your registered clinic or hospital address anywhere across India.

Frequently Asked Questions

Why is Hydroxocobalamin preferred over Cyanocobalamin for veterinary parenteral B12 therapy?

Hydroxocobalamin offers three clinically important pharmacokinetic advantages over the more commonly available and cheaper Cyanocobalamin form. First, it binds avidly to plasma transcobalamin proteins, achieving higher peak tissue B12 concentrations and maintaining them for significantly longer following injection. Second, its longer plasma half-life means effective therapeutic B12 tissue levels are maintained between injections for a more extended period reducing injection frequency requirements and improving practical treatment compliance. Third, unlike Cyanocobalamin which requires hepatic conversion before becoming biologically active, Hydroxocobalamin enters the active coenzyme pool directly delivering faster and more complete therapeutic action in the methylcobalamin and adenosylcobalamin pathways critical for haematological and neurological health respectively.

How quickly will I see clinical improvement after starting parenteral B12 therapy in a B12-deficient dog or cat?

The haematological response to parenteral Hydroxocobalamin therapy in B12-deficient animals is typically rapid and clinically measurable. A reticulocytosis (increase in immature red blood cell precursors in circulation the first sign of haematopoietic recovery) is usually detectable within 5 to 7 days of the first injection. Rising haemoglobin and improving packed cell volume are typically measurable within 2 to 3 weeks. Clinical improvement in appetite, energy level, and body weight in dogs with EPI and cats with chronic disease is often noticed by owners within 2 to 4 weeks of initiating regular parenteral B12 therapy. Neurological improvement in animals with B12 deficiency neuropathy is typically slower requiring 4 to 8 weeks of therapy and is only achievable if treatment is initiated before irreversible axonal damage has occurred.

Why can't B12-deficient animals with EPI or IBD simply take oral B12 supplements instead of injections?

In healthy animals with intact gastrointestinal function, dietary Vitamin B12 absorption occurs through a complex process involving intrinsic factor secretion by the pancreas and stomach, B12-intrinsic factor complex formation, and specific receptor-mediated absorption in the ileum. In dogs with EPI, this process is severely impaired through multiple mechanisms loss of pancreatic intrinsic factor secretion, secondary small intestinal bacterial overgrowth consuming dietary B12 before it can be absorbed, and mucosal malabsorption. In cats and dogs with IBD and chronic enteropathy, ileal mucosal damage impairs receptor-mediated absorption of the B12-intrinsic factor complex. In both conditions, oral B12 supplementation regardless of dose cannot reliably achieve or maintain adequate serum and tissue B12 levels, making parenteral injection the only therapeutically reliable route for B12 repletion in these patients.

Is long-term parenteral B12 supplementation safe for dogs and cats?

Yes Vitamin B12 is a water-soluble vitamin with an extremely wide therapeutic index and no known toxicity at any clinically relevant dose in dogs or cats. Excess Hydroxocobalamin that is not bound to plasma proteins and tissue receptors is safely eliminated in the urine. Long-term monthly or bi-monthly parenteral B12 maintenance therapy is routinely and safely used in dogs with EPI and cats with chronic intestinal disease throughout their entire lives with no adverse effects associated with long-term use. Regular monitoring of serum B12 levels where available helps optimise injection frequency and confirm that maintenance therapy is achieving adequate tissue B12 saturation.

How can veterinary clinics procure Trineurosol-HP Hydroxocobalamin 1000mcg Injection through Animeal?

Registered veterinary practitioners, veterinary clinics, and animal hospitals can enquire about and procure Trineurosol-HP Injection through Animeal's dedicated veterinary pharmaceutical enquiry channel. Please use the Enquire Now button on this product page or contact our veterinary pharma team directly via WhatsApp or phone with your valid veterinary prescription and practice registration details. Our team will respond promptly with product availability, current pricing, pack size options, and delivery arrangements to your registered clinic or hospital address anywhere across India.